BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31531882)

  • 1. FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner.
    Milan M; Balestrieri C; Alfarano G; Polletti S; Prosperini E; Spaggiari P; Zerbi A; Diaferia GR; Natoli G
    EMBO J; 2019 Oct; 38(20):e102161. PubMed ID: 31531882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development.
    Gao N; LeLay J; Vatamaniuk MZ; Rieck S; Friedman JR; Kaestner KH
    Genes Dev; 2008 Dec; 22(24):3435-48. PubMed ID: 19141476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
    Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
    BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analyses identify molecular subtypes of pancreatic cancer.
    Bailey P; Chang DK; Nones K; Johns AL; Patch AM; Gingras MC; Miller DK; Christ AN; Bruxner TJ; Quinn MC; Nourse C; Murtaugh LC; Harliwong I; Idrisoglu S; Manning S; Nourbakhsh E; Wani S; Fink L; Holmes O; Chin V; Anderson MJ; Kazakoff S; Leonard C; Newell F; Waddell N; Wood S; Xu Q; Wilson PJ; Cloonan N; Kassahn KS; Taylor D; Quek K; Robertson A; Pantano L; Mincarelli L; Sanchez LN; Evers L; Wu J; Pinese M; Cowley MJ; Jones MD; Colvin EK; Nagrial AM; Humphrey ES; Chantrill LA; Mawson A; Humphris J; Chou A; Pajic M; Scarlett CJ; Pinho AV; Giry-Laterriere M; Rooman I; Samra JS; Kench JG; Lovell JA; Merrett ND; Toon CW; Epari K; Nguyen NQ; Barbour A; Zeps N; Moran-Jones K; Jamieson NB; Graham JS; Duthie F; Oien K; Hair J; Grützmann R; Maitra A; Iacobuzio-Donahue CA; Wolfgang CL; Morgan RA; Lawlor RT; Corbo V; Bassi C; Rusev B; Capelli P; Salvia R; Tortora G; Mukhopadhyay D; Petersen GM; ; Munzy DM; Fisher WE; Karim SA; Eshleman JR; Hruban RH; Pilarsky C; Morton JP; Sansom OJ; Scarpa A; Musgrove EA; Bailey UM; Hofmann O; Sutherland RL; Wheeler DA; Gill AJ; Gibbs RA; Pearson JV; Waddell N; Biankin AV; Grimmond SM
    Nature; 2016 Mar; 531(7592):47-52. PubMed ID: 26909576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells.
    Bastidas-Ponce A; Roscioni SS; Burtscher I; Bader E; Sterr M; Bakhti M; Lickert H
    Mol Metab; 2017 Jun; 6(6):524-534. PubMed ID: 28580283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice.
    Ye DZ; Kaestner KH
    Gastroenterology; 2009 Dec; 137(6):2052-62. PubMed ID: 19737569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
    Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
    Elife; 2018 Nov; 7():. PubMed ID: 30475207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development.
    Lin W; Metzakopian E; Mavromatakis YE; Gao N; Balaskas N; Sasaki H; Briscoe J; Whitsett JA; Goulding M; Kaestner KH; Ang SL
    Dev Biol; 2009 Sep; 333(2):386-96. PubMed ID: 19607821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
    Vorvis C; Hatziapostolou M; Mahurkar-Joshi S; Koutsioumpa M; Williams J; Donahue TR; Poultsides GA; Eibl G; Iliopoulos D
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1124-37. PubMed ID: 27151939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH.
    Wang R; Shi Y; Chen L; Jiang Y; Mao C; Yan B; Liu S; Shan B; Tao Y; Wang X
    Sci Rep; 2015 Dec; 5():17826. PubMed ID: 26658322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner.
    Ferri AL; Lin W; Mavromatakis YE; Wang JC; Sasaki H; Whitsett JA; Ang SL
    Development; 2007 Aug; 134(15):2761-9. PubMed ID: 17596284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
    Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
    Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
    Song Y; Washington MK; Crawford HC
    Cancer Res; 2010 Mar; 70(5):2115-25. PubMed ID: 20160041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forkhead box transcription factors Foxa1 and Foxa2 are important regulators of Muc2 mucin expression in intestinal epithelial cells.
    van der Sluis M; Vincent A; Bouma J; Korteland-Van Male A; van Goudoever JB; Renes IB; Van Seuningen I
    Biochem Biophys Res Commun; 2008 May; 369(4):1108-13. PubMed ID: 18336786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FOXA1 transcriptional network coordinates key functions of primary human airway epithelial cells.
    Paranjapye A; Mutolo MJ; Ebron JS; Leir SH; Harris A
    Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L126-L136. PubMed ID: 32432922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
    Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
    Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many variants.
    Milan M; Diaferia GR; Natoli G
    EMBO J; 2021 Jul; 40(13):e107206. PubMed ID: 33844319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
    Roe JS; Hwang CI; Somerville TDD; Milazzo JP; Lee EJ; Da Silva B; Maiorino L; Tiriac H; Young CM; Miyabayashi K; Filippini D; Creighton B; Burkhart RA; Buscaglia JM; Kim EJ; Grem JL; Lazenby AJ; Grunkemeyer JA; Hollingsworth MA; Grandgenett PM; Egeblad M; Park Y; Tuveson DA; Vakoc CR
    Cell; 2017 Aug; 170(5):875-888.e20. PubMed ID: 28757253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
    He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
    Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.